Boyle, a most skeptical chemist.

Stec EM, Vannucci SJ, Smith QR: Blood-brain barrier glucose transporter: effects of hypoand hyperglycemia revisited. J Neurochem 1999; 72:238–47 42. Preiser J-C: Restoring normoglycemia: Not so harmless. Critical Care (London, England) 2008; 12:116 43. Wilson M, Weinreb J, Hoo GWS: Intensive insulin therapy in critical care: A review of 12 protocols. Diabetes Care 2007; 30:1005–11 44. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471–8 45. Bode BW, Braithwaite SS, Steed RD, Davidson PC: Intravenous insulin infusion therapy: Indications, methods, and transition to subcutaneous insulin therapy. Endocrine Practice 2004; 10 Suppl 2:71–80 46. Egi M, Bellomo R, Stachowski E, French CJ, Hart G: Variability of blood glucose concentration and short-term mortality in critically ill patients. ANESTHESIOLOGY 2006; 105:244–52 47. Molyneux AJ, Kerr RSC, Yu L-M, Clarke M, Sneade M, Yarnold JA, Sandercock P: International Subarachnoid Aneurysm Trial Collaborative G International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005; 366:809–17